|
|
Volumn 16 Suppl 1, Issue , 2011, Pages 71-78
|
|
Directed therapy of subtypes of triple-negative breast cancer.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
EPIDERMAL GROWTH FACTOR RECEPTOR 2;
ESTROGEN RECEPTOR;
PROGESTERONE RECEPTOR;
ADJUVANT CHEMOTHERAPY;
ARTICLE;
BREAST TUMOR;
FEMALE;
GENETICS;
HUMAN;
METABOLISM;
METHODOLOGY;
MOLECULARLY TARGETED THERAPY;
PATHOLOGY;
ANTINEOPLASTIC AGENTS;
BREAST NEOPLASMS;
CHEMOTHERAPY, ADJUVANT;
FEMALE;
HUMANS;
MOLECULAR TARGETED THERAPY;
RECEPTOR, ERBB-2;
RECEPTORS, ESTROGEN;
RECEPTORS, PROGESTERONE;
|
|
EID: 79959524883
PISSN: None
EISSN: 1549490X
Source Type: Journal
DOI: 10.1634/theoncologist.2011-S1-71 Document Type: Article |
|
Times cited : (78)
|
|
References (0)
|
